Clinical Trial Update: Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [NA]

View source ↗

Summary

Completed clinical trial evaluating quality of life and survivorship care for patients undergoing HIPEC for peritoneal cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Carcinoma
• Colon Cancer
• Malignant Mesothelioma
• Ovarian Epithelial Cancer
• Pseudomyxoma Peritonei

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Advanced Malignant Mesothelioma, Carcinoma of the Appendix | NA | Status: COMPLETED